Test Price
2,800 AED✅ Home Collection Available
KCNT1 Gene Early Infantile Epileptic Encephalopathy Type 14 (EIEE14) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee
99.9% Diagnostic Sensitivity – all testing performed in an ISO 9001:2015 certified facility (Cert: INT/EGQ/2509DA/3139).
Premium Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance
Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed medical geneticist.
Insurance Support
Direct Billing Verification via WhatsApp: +971 54 548 8731 – we handle pre‑authorization for you.
Regulatory Compliance
Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Result Turnaround
3 to 4 Weeks – urgent reporting available upon request.
Test Overview & Methodology
The KCNT1 gene test screens for pathogenic variants responsible for Early Infantile Epileptic Encephalopathy Type 14, a severe neonatal‑onset developmental and epileptic disorder. This next‑generation sequencing (NGS) assay delivers a molecular diagnosis that directly informs clinical management and genetic counselling.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) covering the entire KCNT1 coding region with copy‑number analysis | Sanger sequencing – typically analyses one exon at a time, missing large deletions/duplications |
| Diagnostic Sensitivity | 99.9% for single‑nucleotide variants and indels | ~97% – limited to point mutations; structural variants often missed |
| Turnaround Time | 3–4 weeks | 6–8 weeks (multi‑step, lower throughput) |
| Sample Type | Whole blood, extracted DNA, or one drop blood on FTA card | Whole blood (usually 3–5 mL) |
| Price | 2800 AED | ~3500–4500 AED |
Physician Insight & Safety Protocols
“A positive KCNT1 variant must be interpreted within the full clinical context – EEG patterns, seizure semiology, and developmental milestones are equally vital. I urge families not to alter anti‑epileptic regimens solely based on a genetic report, and to always consult a pediatric neurologist for tailored treatment.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Abrupt seizure‑medication withdrawal can trigger life‑threatening status epilepticus.
Safety Exclusion & Emergency Red Flags
Exclusion Criteria & Red Flags
- Exclusion Criteria: Patients with active severe bleeding disorders; inability to provide any biological sample; test not intended for asymptomatic population screening.
- Emergency Red Flags – seek immediate medical help if: seizure lasts >5 minutes, difficulty breathing, loss of consciousness, fever >38°C, or any new focal neurological deficit after sampling.
Patient FAQ & Clinical Guidance
1. What is the KCNT1 EIEE14 test and how is it performed?
Snippet: This test sequences the KCNT1 gene using a blood or FTA card sample to detect epilepsy‑causing mutations. Simply provide a small blood sample (or one drop on an FTA card) during our home collection; DNA is extracted and analysed via high‑coverage NGS. The report details any disease‑associated variants with clinical interpretation.
2. How accurate is the test, and does it require genetic counselling?
Snippet: Diagnostic sensitivity is 99.9% for single‑nucleotide variants, backed by ISO 9001:2015 quality processes. Pre‑test genetic counselling is mandatory – we arrange a session to draw a family pedigree and explain implications. Post‑test guidance is also included to help parents understand results and inheritance risks.
3. Will insurance cover the test and what is the process for home collection?
Snippet: Most UAE insurers reimburse this when pre‑authorized – our billing team verifies coverage directly via WhatsApp. Home collection happens at your convenience (8 AM–11 PM) using cold‑chain transport; a trained phlebotomist collects blood or an FTA card sample painlessly. Results are delivered digitally in 3–4 weeks with a tele‑consultation.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance
This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is encrypted, access-controlled, and processed only for diagnostic purposes. Clinical safety and consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | KCNT1 Gene Early Infantile Epileptic Encephalopathy Type 14 (EIEE14) Genetic Test |
| Price (AED) | 2800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or one drop blood on FTA card |
| Methodology Used | Next-Generation Sequencing (NGS) covering entire coding region with copy-number analysis |
| ICD-10-CM Code | G40.4 |
| LOINC Code | 93014-4 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians